Literature DB >> 10622613

Presumptive Babesia ovis infection in a spanish ibex (Capra pyrenaica).

I Marco1, R Velarde, J Castellà, D Ferrer, S Lavín.   

Abstract

On December 29 1995, a 13-year old, male Spanish ibex was easily captured by hand, with depression, weakness and severe tick infestation, mainly in the periocular and auricular regions. Blood and serum samples were collected and haematological analysis and serum iron levels were determined. Red blood cell count, haematocrit, haemoglobin concentration and mean corpuscular haemoglobin concentration (MCHC) were decreased and mean corpuscular volume (MCV) increased (macrocytic-hypochromic anemia). Serum iron and transferrin saturation were decreased and total and unbound iron-binding capacity were increased. Piroplasms were observed within parasitized erythrocytes and presumptively identified as Babesia spp. Ticks were identified exclusively as Ripicephalus bursa. The animal was treated with imidocarb but died after 15 days of capture. Histopathological examination revealed congestion of pulmonary capillaries and spleen, glomerulonephritis, hemoglobinuric nephrosis and generalized hemosiderosis. An indirect fluorescent antibody test was performed using a Babesia ovis isolate of ovine origin as antigen and the animal was positive with a titre of 1:640.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10622613     DOI: 10.1016/s0304-4017(99)00170-3

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  2 in total

Review 1.  A survey of the transmission of infectious diseases/infections between wild and domestic ungulates in Europe.

Authors:  Claire Martin; Paul-Pierre Pastoret; Bernard Brochier; Marie-France Humblet; Claude Saegerman
Journal:  Vet Res       Date:  2011-06-02       Impact factor: 3.683

2.  Babesia spp. in European wild ruminant species: parasite diversity and risk factors for infection.

Authors:  Adam O Michel; Alexander Mathis; Marie-Pierre Ryser-Degiorgis
Journal:  Vet Res       Date:  2014-06-13       Impact factor: 3.683

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.